Skip to main content

Table 1 Patients’ characteristics

From: Behavior of FDG-avid supradiaphragmatic lymph nodes in PET/CT throughout primary therapy in advanced serous epithelial ovarian cancer: a prospective study

Variables Patients (n) %
Total 41 100
Age, median (years,range) 63 (30–80)  
FIGO stage   
 IIIB 2 4.9
 IIIC 18 43.9
 IVA 6 14.6
 IVB 15 36.6
Histology
 High grade serous 37 90.2
 Low grade serous 4 9.8
Treatment strategy   
 Primary debulking surgery 12 29.3
 Neoadjuvant chemotherapy 29 70.7
 Interval debulking surgery 24 58.5
PDS outcome
 No residual tumor 3 25.0
 Residual tumor size < 1 cm 4 33.3
 Residual tumor size > 1 cm 5 41.7
IDS outcome
 No residual tumor 6 25.0
 Residual tumor size < 1 cm 17 70.8
 Residual tumor size > 1 cm 1 4.2
Primary treatment outcome
 Complete response 20 48.8
 Partial response 9 22.0
 Stable disease 0 0
 Progressive disease 12 29.2
Recurrence rate after completion of first line therapy (N = 29)
 All patients 26 89.7
 Complete response 14 46.2
 Partial response 12 53.8